In late November, two former senior executives of Synthes Inc. were sentenced to nine months in prison and a third sentenced to five months in prison for their management roles in a company that marketed a medical device for an unauthorized use and conducted unauthorized clinical trials. Each defendant was also ordered to pay $100,000 in fines and will face a period of supervised release after leaving prison. Another executive, the former vice president of operations, has not yet been sentenced.
Click the link below to read the full alert.